Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Actigraphy Improvement With Voxelotor (ActIVe) Study

ClinicalTrials.gov ID: NCT04400487

Public ClinicalTrials.gov record NCT04400487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multicenter, Open-label Study to Evaluate the Treatment Effect of Voxelotor on Physical Activity in Adolescents and Adults With Sickle Cell Disease

Study identification

NCT ID
NCT04400487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • Voxelotor Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2020
Primary completion
Sep 7, 2022
Completion
Sep 12, 2022
Last update posted
Nov 20, 2023

2020 – 2022

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
UConn Health Farmington Connecticut 06030
Children's Healthcare of Atlanta Atlanta Georgia 30342
Children's Hospital of Michigan Detroit Michigan 48201
Icahn School of Medicine at Mount Sinai New York New York 10029
The Children's Hospital at Montefiore The Bronx New York 10476
Duke Department of Pediatrics Durham North Carolina 27710
The Ohio State University Wexner Medical Center Columbus Ohio 43210
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
The University of Texas Health Science Center at Houston Houston Texas 77030
VCU Health Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04400487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04400487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →